Maarten Kooyman

Maarten Kooyman

Auto-generated profile, based on publicly available information

Maarten Kooyman

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
RLRichard Karlsson Linnér
Richard Karlsson Linnér
PBPietro Biroli
Pietro Biroli
EKEdward Kong
Edward Kong
SMS. Fleur W. Meddens
S. Fleur W. Meddens
RWRobbee Wedow
Robbee Wedow
JBJonathan P. Beauchamp
Jonathan P. Beauchamp
Humans vary substantially in their willingness to take risks. In a combined sample of over 1 million individuals, we conducted genome-wide association studies (GWAS) of general risk tolerance, adventurousness, and risky behaviors in the driving, drinking, smoking, and sexual domains. Across all GWAS, we identified hundreds of associated loci, including 99 loci associated with general risk tolerance. We report evidence of substantial shared genetic influences across risk tolerance and the risky behaviors: 46 of the 99 general risk tolerance loci contain a lead SNP for at least one of our other GWAS, and general risk tolerance is genetically correlated (\(\left| {\hat r_{\mathrm{g}}} \right|\) ~ 0.25 to 0.50) with a range of risky behaviors. Bioinformatics analyses imply that genes near SNPs associated with general risk tolerance are highly expressed in brain tissues and point to a role for glutamatergic and GABAergic neurotransmission. We found no evidence of enrichment for genes previously hypothesized to relate to risk tolerance.

1 March 2018 in Neuron
Verified
Journal Article
Closed access
ANAude Nicolas
Aude Nicolas
KKKevin P. Kenna
Kevin P. Kenna
ARAlan E. Renton
Alan E. Renton
NTNicola Ticozzi
Nicola Ticozzi
FFFaraz Faghri
Faraz Faghri
NTNatalie A. Twine
Natalie A. Twine

6 December 2021 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WRWouter van Rheenen
Wouter van Rheenen
RSRick A. A. van der Spek
Rick A. A. van der Spek
MBMark K. Bakker
Mark K. Bakker
JVJoke J. F. A. van Vugt
Joke J. F. A. van Vugt
PHPaul J. Hop
Paul J. Hop
JVJan H. Veldink
Jan H. Veldink
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk of one in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry genome-wide association study (GWAS) including 29,612 patients with ALS and 122,656 controls, which identified 15 risk loci. When combined with 8,953 individuals with whole-genome sequencing (6,538 patients, 2,415 controls) and a large cortex-derived expression quantitative trait locus (eQTL) dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, short tandem repeats or regulatory effects. ALS-associated risk loci were shared with multiple traits within the neurodegenerative spectrum but with distinct enrichment patterns across brain regions and cell types. Of the environmental and lifestyle risk factors obtained from the literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. The combination of all ALS-associated signals reveals a role for perturbations in vesicle-mediated transport and autophagy and provides evidence for cell-autonomous disease initiation in glutamatergic neurons.

8 September 2017 in Genome Research
Verified
Journal Article
Open access
PDF file
EDEgor Dolzhenko
Egor Dolzhenko
JVJoke J.F.A. van Vugt
Joke J.F.A. van Vugt
RSRichard J. Shaw
Richard J. Shaw
MBMitchell A. Bekritsky
Mitchell A. Bekritsky
MBMarka van Blitterswijk
Marka van Blitterswijk
MEMichael A. Eberle
Michael A. Eberle
Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an important step toward integrating WGS into precision medicine. We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4). Additionally, 99.9% (2786/2789, 95% CI [0.997, 1.00]) of the wild-type samples were correctly classified as wild type by this method with the remaining three samples identified as possible expansions. We further applied our algorithm to a set of 152 samples in which every sample had one of eight different pathogenic repeat expansions, including those associated with fragile X syndrome, Friedreich's ataxia, and Huntington's disease, and correctly flagged all but one of the known repeat expansions. Thus, ExpansionHunter can be used to accurately detect known pathogenic repeat expansions and provides researchers with a tool that can be used to identify new pathogenic repeat expansions.

10 June 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
PHPaul J. Hop
Paul J. Hop
DLDongbing Lai
Dongbing Lai
PKPamela J. Keagle
Pamela J. Keagle
DBDesiree M. Baron
Desiree M. Baron
BKBrendan J. Kenna
Brendan J. Kenna
JLJohn E. Landers
John E. Landers
Despite substantial progress, causal variants are identified only for a minority of familial Parkinson’s disease (PD) cases, leaving high-risk pathogenic variants unidentified1,2. To identify such variants, we uniformly processed exome sequencing data of 2,184 index familial PD cases and 69,775 controls. Exome-wide analyses converged on RAB32 as a novel PD gene identifying c.213C > G/p.S71R as a high-risk variant presenting in ~0.7% of familial PD cases while observed in only 0.004% of controls (odds ratio of 65.5). This variant was confirmed in all cases via Sanger sequencing and segregated with PD in three families. RAB32 encodes a small GTPase known to interact with LRRK2 (refs. 3,4). Functional analyses showed that RAB32 S71R increases LRRK2 kinase activity, as indicated by increased autophosphorylation of LRRK2 S1292. Here our results implicate mutant RAB32 in a key pathological mechanism in PD—LRRK2 kinase activity5–7—and thus provide novel insights into the mechanistic connections between RAB family biology, LRRK2 and PD risk.

19 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NPNicola Pirastu
Nicola Pirastu
MKMaarten Kooyman
Maarten Kooyman
MTMichela Traglia
Michela Traglia
ARAntonietta Robino
Antonietta Robino
SWSara M Willems
Sara M Willems
PGPaolo Gasparini
Paolo Gasparini
Coffee, one of the most popular beverages in the world, contains many different physiologically active compounds with a potential impact on people’s health. Despite the recent attention given to the genetic basis of its consumption, very little has been done in understanding genes influencing coffee preference among different individuals. Given its markedly bitter taste, we decided to verify if bitter receptor genes (TAS2Rs) variants affect coffee liking. In this light, 4066 people from different parts of Europe and Central Asia filled in a field questionnaire on coffee liking. They have been consequently recruited and included in the study. Eighty-eight SNPs covering the 25 TAS2R genes were selected from the available imputed ones and used to run association analysis for coffee liking. A significant association was detected with three SNP: one synonymous and two functional variants (W35S and H212R) on the TAS2R43 gene. Both variants have been shown to greatly reduce in vitro protein activity. Surprisingly the wild type allele, which corresponds to the functional form of the protein, is associated to higher liking of coffee. Since the hTAS2R43 receptor is sensible to caffeine, we verified if the detected variants produced differences in caffeine bitter perception on a subsample of people coming from the FVG cohort. We found a significant association between differences in caffeine perception and the H212R variant but not with the W35S, which suggests that the effect of the TAS2R43 gene on coffee liking is mediated by caffeine and in particular by the H212R variant. No other significant association was found with other TAS2R genes. In conclusion, the present study opens new perspectives in the understanding of coffee liking. Further studies are needed to clarify the role of the TAS2R43 gene in coffee hedonics and to identify which other genes and pathways are involved in its genetics.